Early Success For 4D Pharma’s Microbiome Plus Keytruda Combination

Micro-Cap Stock Rises

 
• By Andrew McConaghie
  
Bacteria
4D Pharma's 'live biotherapeutic' aims to activate a patient's immune system and enable a response to checkpoint inhibitor Keytruda
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D